# Cost of Cancer Diagnosis Using Next-generation Sequencing Targeted Gene Panels in Routine Practice

> **NCT04656717** · — · COMPLETED · sponsor: **Fondation Ophtalmologique Adolphe de Rothschild** · enrollment: 15 (actual)

## Conditions studied

- Cancer

## Interventions

- **OTHER:** Measure of the total cost of performing next-generation sequencing (NGS)

## Key facts

- **NCT ID:** NCT04656717
- **Lead sponsor:** Fondation Ophtalmologique Adolphe de Rothschild
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2015-11
- **Final completion:** 2015-11
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2020-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04656717

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04656717, "Cost of Cancer Diagnosis Using Next-generation Sequencing Targeted Gene Panels in Routine Practice". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04656717. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*